Similar articles for PMID: 15471821

Year	Number of Results
1998	1
1999	1
2001	1
2002	2
2003	4
2004	7
2005	12
2006	8
2007	9
2008	4
2009	6
2010	4
2011	5
2012	1
2013	5
2014	3
2015	1
2016	2
2019	1
2020	1
2021	1
2022	0

1

18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis.

Belhocine TZ. Belhocine TZ. J Nucl Med. 2004 Oct;45(10):1602-4. J Nucl Med. 2004. PMID: 15471821 Free article. No abstract available.

2

Defining the priority of using 18F-FDG PET for recurrent cervical cancer.

Yen TC, See LC, Chang TC, Huang KG, Ng KK, Tang SG, Chang YC, Hsueh S, Tsai CS, Hong JH, Lin CT, Chao A, Ma SY, Lin WJ, Fu YK, Fan CC, Lai CH. Yen TC, et al. J Nucl Med. 2004 Oct;45(10):1632-9. J Nucl Med. 2004. PMID: 15471826 Free article. Clinical Trial.

3

Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.

Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW. Schwarz JK, et al. JAMA. 2007 Nov 21;298(19):2289-95. doi: 10.1001/jama.298.19.2289. JAMA. 2007. PMID: 18029833

4

Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.

Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, Park SY. Chung HH, et al. Gynecol Oncol. 2006 Oct;103(1):165-70. doi: 10.1016/j.ygyno.2006.02.016. Epub 2006 Mar 29. Gynecol Oncol. 2006. PMID: 16574205

5

False-positive rate of posttherapy positron emission tomography in cervical cancer.

Oxnard GR. Oxnard GR. JAMA. 2008 Feb 27;299(8):898; author reply 898. doi: 10.1001/jama.299.8.898-a. JAMA. 2008. PMID: 18314432 No abstract available.

6

Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.

Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Grigsby PW, et al. J Clin Oncol. 2004 Jun 1;22(11):2167-71. doi: 10.1200/JCO.2004.09.035. J Clin Oncol. 2004. PMID: 15169804

7

FDG-PET Imaging in Cervical Cancer.

Gandy N, Arshad MA, Park WE, Rockall AG, Barwick TD. Gandy N, et al. Semin Nucl Med. 2019 Nov;49(6):461-470. doi: 10.1053/j.semnuclmed.2019.06.007. Epub 2019 Jun 24. Semin Nucl Med. 2019. PMID: 31630730 Review.

8

The role of FDG-PET/CT imaging after radiation therapy.

Grigsby PW. Grigsby PW. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S27-9. doi: 10.1016/j.ygyno.2007.07.034. Epub 2007 Aug 28. Gynecol Oncol. 2007. PMID: 17727930 No abstract available.

9

Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.

Spottswood SE, Lopatina OA, Fey GL, Boardman CH. Spottswood SE, et al. Clin Nucl Med. 2005 Jan;30(1):56-9. doi: 10.1097/00003072-200501000-00022. Clin Nucl Med. 2005. PMID: 15604978 No abstract available.

10

PET/CT imaging to guide cervical cancer therapy.

Grigsby PW. Grigsby PW. Future Oncol. 2009 Sep;5(7):953-8. doi: 10.2217/fon.09.70. Future Oncol. 2009. PMID: 19792965 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed